MX2015009037A - Enjuague nasal con miel. - Google Patents

Enjuague nasal con miel.

Info

Publication number
MX2015009037A
MX2015009037A MX2015009037A MX2015009037A MX2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A MX 2015009037 A MX2015009037 A MX 2015009037A
Authority
MX
Mexico
Prior art keywords
honey
nasal rinse
nasal
carrier
methods
Prior art date
Application number
MX2015009037A
Other languages
English (en)
Inventor
Roland Clifford Park
Kenneth Gene Rayl
Ian Joseph Alexander
Original Assignee
Ent Associates Of Los Alamos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ent Associates Of Los Alamos Llc filed Critical Ent Associates Of Los Alamos Llc
Publication of MX2015009037A publication Critical patent/MX2015009037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

Se describen composiciones de enjuague nasal novedosas. El enjuague nasal comprende un particulado deshidratado compuesto de miel y un portador. La composición puede ser una composición co-procesada en donde la miel y el portador se combinan mientras que la miel está en forma líquida y se procesan conjuntamente para producir el particulado deshidratado. También se proporcionan métodos para producir las composiciones de enjuague nasal, así como métodos de uso de las composiciones de enjuague nasal para la prevención o tratamiento de infección nasal, rinitis o sinusitis.
MX2015009037A 2013-01-14 2014-01-14 Enjuague nasal con miel. MX2015009037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361752053P 2013-01-14 2013-01-14
PCT/US2014/011500 WO2014110580A1 (en) 2013-01-14 2014-01-14 Honey nasal rinse

Publications (1)

Publication Number Publication Date
MX2015009037A true MX2015009037A (es) 2016-07-13

Family

ID=51165297

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009037A MX2015009037A (es) 2013-01-14 2014-01-14 Enjuague nasal con miel.

Country Status (8)

Country Link
US (3) US20140199266A1 (es)
EP (1) EP2943252A1 (es)
JP (1) JP2016505022A (es)
CN (1) CN105658281A (es)
AU (1) AU2014205065A1 (es)
CA (1) CA2898040A1 (es)
MX (1) MX2015009037A (es)
WO (1) WO2014110580A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
AU2014205065A1 (en) * 2013-01-14 2015-07-30 Ent Associates Of Los Alamos, Llc Honey nasal rinse
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
US11839601B2 (en) 2016-04-19 2023-12-12 Canna-B Cure Ltd Cannabis-enriched enzymatically treated therapeutic composition
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions
FR3073737B1 (fr) * 2017-11-23 2020-10-09 Ainura Chodoeva La methode de traitement de la rhinosinusite
CN108567797A (zh) * 2018-03-26 2018-09-25 刘洪武 一种蚯蚓洗液
CN111821368A (zh) * 2019-04-19 2020-10-27 鼻精灵(重庆)医疗科技有限公司 一种治疗鼻炎的组合物及含该组合物的鼻炎膏
CN112773764A (zh) * 2019-11-11 2021-05-11 鼻精灵(重庆)医疗科技有限公司 一种护鼻水
EP4061337A1 (en) * 2019-11-18 2022-09-28 Otosan S.r.l. Soluble preparation for nasal douches, corresponding nasal irrigation kit and operating procedure for carrying out nasal douches
WO2021206566A1 (en) * 2020-04-06 2021-10-14 ManukaMed Limited Partnership Viral treatments involving manuka honey and components thereof
US20210315849A1 (en) * 2020-04-10 2021-10-14 Pacific Sinus Solutions LLC Compositions and methods for treating one or more ailments with a nasal rinse comprising n-acetylcysteine
CN111956667A (zh) * 2020-08-26 2020-11-20 北京达熙生物科技有限公司 多功能干细胞外泌体和间充质干细胞裂解物在制备治疗过敏性鼻炎药物中的应用
AU2022200728A1 (en) * 2022-02-03 2023-08-17 HAGGART, Ethan Tobias Grey Nasal spray formula for the prevention of contracting COVID19 and DELTA and Omnicom.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919956A (en) * 1985-01-17 1990-04-24 Ogilvie Mills, Inc. Methods for drying honey and molasses
DE4022058C2 (de) * 1990-07-11 1996-05-23 Oetker Nahrungsmittel Honigpulver und Verfahren zu seiner Herstellung
US5980875A (en) * 1996-04-12 1999-11-09 Mousa; Mahmoud A. Honey preparations
GB2347859B (en) * 1999-03-19 2004-02-25 Yasin Nazir Karim Yakub Herbal compositions
US8568790B2 (en) * 2006-05-31 2013-10-29 Medihoney Pty Ltd. Medicinal compositions containing honey
JP2010095454A (ja) * 2008-10-14 2010-04-30 Cyclochem:Kk 抗菌組成物
US20120021060A1 (en) * 2010-07-21 2012-01-26 Amin Ramzanali Javer Honey Compositions and Uses Thereof
US8709505B2 (en) * 2011-02-14 2014-04-29 Juliet Agatha Boghossian Therapeutic rinse in a self-heating package
EP2680866A1 (en) * 2011-03-01 2014-01-08 Quorum Innovations, LLC Materials and methods for treating conditions associated with pathogenic biofilm
US20120294952A1 (en) * 2011-05-18 2012-11-22 Zarbees, Inc. Antitussive compositions and methods
AU2014205065A1 (en) * 2013-01-14 2015-07-30 Ent Associates Of Los Alamos, Llc Honey nasal rinse

Also Published As

Publication number Publication date
AU2014205065A1 (en) 2015-07-30
EP2943252A1 (en) 2015-11-18
JP2016505022A (ja) 2016-02-18
US20150297644A1 (en) 2015-10-22
US20150182563A1 (en) 2015-07-02
WO2014110580A1 (en) 2014-07-17
CA2898040A1 (en) 2014-07-17
CN105658281A (zh) 2016-06-08
US20140199266A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
MX2015009037A (es) Enjuague nasal con miel.
PH12015501703A1 (en) Trifluormethyl-substituted ring-fused pyrimidines and use thereof
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
PH12014501595A1 (en) Substituted annulated pyrimidines and triazines, and use thereof
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
IN2015DN01156A (es)
MX2019008122A (es) Derivados de aminas heterociclicas que inhiben la transduccion de se?al mediada por cinasa asociada con el receptor de interleucina-1.
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
CN104812762A8 (zh) 取代的环状嘧啶和三嗪以及它们的用途
MX2015010125A (es) Derivados de piridazinona-amidas.
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
MX2015010921A (es) Compuestos de carbazol utiles como inhibidores de bromodominio.
EP2827869A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING THE THERAPEUTIC BENEFIT OF INDIRUBIN AND ITS ANALOGUES INCLUDING MESOINDIGO
MX2015009209A (es) Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y metodos de tratamiento con los mismos.
IN2014DN06104A (es)
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
EA201600096A1 (ru) Бензил-1н-пиразол[3,4-b]пиридины и их применение
PH12015502118A1 (en) Pyridin-4-yl derivatives
UA116239C2 (uk) Нові похідні піридину
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
IN2013CH04330A (es)
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2015024992A3 (en) Treatment of asthma